Prebiotics and lipid metabolism

Current Opinion in Lipidology

Volumn 13, Issue 1, 2002, Pages 61-67

  Delzenne, Nathalie M ^a   Williams, Christine M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CHOLESTEROL; FRUCTAN; GALACTOMANNAN; GALACTOSE; GLUCOSE DERIVATIVE; LIPID; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; STARCH; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XYLOSE;

BACTERIAL GROWTH; BIFIDOBACTERIUM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLON FLORA; DIET; HUMAN; HYPERLIPIDEMIA; LACTOBACILLUS; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SOYBEAN;

ANIMALS; BIFIDOBACTERIUM; CARDIOVASCULAR DISEASES; COLON; FERMENTATION; FRUCTANS; HUMANS; HYPERLIPIDEMIAS; LACTOBACILLUS; LIPID METABOLISM; LIPIDS; OLIGOSACCHARIDES; PROBIOTICS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036176278     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200202000-00009     Document Type: Review

References (53)

1. Pro- and prebiotics: The tasty guardian angels?
2. Dietary fructans
3. Prebiotics: Preferential substrates for specific germs?
4. Fructo-oligosaccharide malabsorption: Benefit for gastrointestinal functions
5. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics
6. Prebiotic digestion and fermentation
7. Short chain fatty acids
8. Beneficial health effects of low-digestible carbohydrate consumption
9. Actions of non-digestible carbohydrates on blood lipids in humans and animals
10. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use
11. Nondigestible oligosaccharides
12. The prebiotic properties of oligofructose at low intake levels
13. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans
14. Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species
15. In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria
16. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dog
17. Studies on the effects of polydextrose intake on physiologic functions in Chinese people
18. Non polyol low-digestible carbohydrates: Food applications and functional benefits
19. In vitro fermentation of polysaccharides of rye, wheat and oat brans and inulin by human fecal bacteria
20. Whole wheat and triticale flours with different viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats
21. Resistant starches
22. Class 2 resistant starches lower plasma and liver lipids and improve mineral retention in rats
23. Impact of nondigestible carbohydrates on serum lipoproteins and risks of cardiovascular disease
24. Postprandial lipid metabolism: Effects of dietary fatty acids
25. Effects of fructans-type prebiotics on lipid metabolism
26. Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats
27. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats
28. Effects of soluble corn bran arabionoxylans on cecal digestion, lipid metabolism, and mineral balance (Ca, Mg) in rats
29. Low density lipoprotein receptor mRNA in rat liver is affected by resistant starch of beans
30. Actions of non-digestible carbohydrates on blood lipids in humans and animals
31. Inulin and oligofructose: Effect on lipid metabolism
32. Dietary fructans and lipid metabolism: Building a bridge from the colon to the liver
33. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes
34. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics
35. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men
36. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women
37. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease
38. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins
39. Oat β-glucan lowers total and LDL-cholesterol
40. Health effects of probiotics and prebiotics. A literature review on human studies
41. Effects of probiotics and prebiotics on blood lipids
42. Effects of 8 weeks intake of probiotic milk products on risk factors for cardiovascular diseases
43. Probiotics in clinical practice: A critical review of the evidence
44. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism
45. In vitro digestibilility and fermentability of levan and its hypocholesterolemic effects in rats
46. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998
47. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats
48. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers
49. Colonic bacteria activity and serum lipid factors for cardiovascular disease
50. Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men
51. Impact of β-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters
52. Colonic food: Pre- and probiotics
53. An oat containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women